ANAB
AnaptysBio Inc
53.90$
-1.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.2% | -55.0% | -54.1% | -194.4% | -970.1% | -869.0% | -18.9% | -72.7% | -715.4% | -704.1% | -148.3% | 8.4% | |
| 1.9% | 1.6% | 1.4% | 1.8% | 6.3% | 6.4% | 0.7% | 3.3% | 22.7% | 13.8% | 2.6% | 1.0% | |
| 1.0% | 3.4% | 7.0% | 43.8% | 199.2% | 155.1% | 15.3% | 24.3% | 265.9% | 193.5% | 37.3% | 15.4% | |
| 9.4% | 11.3% | 12.1% | 63.7% | -11.7% | 8.5% | 16.0% | 3.1% | 180.8% | – | – | – | |
| 58.5% | -37.2% | -42.1% | 40.8% | 69.2% | 210.6% | -9.0% | -11.9% | 66.5% | -1.9% | -72.7% | -34.4% | |
| 0.9% | 1.4% | 0.3% | 2.9% | 21.3% | 10.1% | 0.8% | 2.2% | 3.5% | 4.7% | 0.4% | 0.0% | |
| -0.9% | -1.4% | -0.3% | -2,430.6% | -2,849.0% | 1,642.9% | 126.0% | 61.5% | -3,838.3% | 843.7% | 104.5% | 97.2% | |
| – | – | – | 0.0% | – | – | – | – | – | 68.3% | – | – | |
| 1.0% | 232.5% | 0.0% | 2,940.5% | 4,605.4% | 37.6% | 0.7% | 4.0% | 115.0% | -291.4% | -0.5% | -29.3% | |
| 31.6% | 56.9% | 59.9% | -68.8% | -137.5% | -93.8% | -1.8% | 0.0% | 0.0% | – | – | – | |
| 31.0% | 224.3% | 51.7% | 2,924.5% | 4,467.3% | -56.2% | -1.2% | 399.4% | 427.9% | -345.6% | 139.2% | -56.5% | |
| 122.4% | 167.9% | -2.7% | 299.6% | 648.1% | 717.8% | 105.9% | 388.1% | -4,125.8% | -206.0% | 95.4% | 49.1% | |
| 91.3% | -56.4% | -54.4% | -197.3% | -991.4% | -879.0% | -19.6% | -74.8% | -718.9% | -708.8% | -148.7% | 8.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.